| |
N
|
Percentage of recalibration (number of patients retained)
|
Recalibration category 1 to category 2
|
Recalibration category 2 to category 1
|
Recalibration category 3 to category 2
|
Recalibration category 3 to category 4
|
Recalibration category 4 to category 3
|
Categories 3 and 4 dispersed
|
|---|
|
Body image
|
T1-T2_Ra
|
68
|
29% (236)
|
Q9-Q12
|
Q9-Q12
| | |
Q9, Q10
|
Q9-Q12
|
|
(Q9-Q12)
|
T1-T3_Rb
|
119
|
50% (238)
|
Q9-Q12
|
Q9-Q12
| |
Q9, Q12
| |
Q9-Q12
|
| |
T3-T4_Rc
|
153
|
63% (244)
|
Q9, Q10
|
Q9, Q10
| | | |
Q9-Q12
|
|
Sexual functioning
|
T1-T2_R
|
55
|
25% (219)
|
Q14
| |
Q14
| | | |
|
(Q14, Q15)
|
T1-T3_R
|
71
|
34% (210)
|
Q14
| |
Q14, Q15
| | | |
| |
T3-T4_R
|
78
|
37% (213)
|
Q14, Q15
|
Q14, Q15
|
Q14, Q15
| | | |
|
Sexual enjoyment
|
T1-T2_R
|
13
|
13% (99)
|
Q16
|
Q16
|
Q16
|
Q16
|
Q16
| |
|
(Q16)
|
T1-T3_R
|
39
|
39% (100)
|
Q16
|
Q16
|
Q16
|
Q16
|
Q16
| |
| |
T3-T4_R
|
33
|
31% (108)
|
Q16
|
Q16
|
Q16
|
Q16
|
Q16
| |
|
Future perspectives
|
T1-T2_R
|
122
|
47% (261)
|
Q13
|
Q13
|
Q13
|
Q13
|
Q13
| |
|
(Q13)
|
T1-T3_R
|
135
|
52% (259)
|
Q13
|
Q13
| |
Q13
|
Q13
| |
| |
T3-T4_R
|
144
|
54% (269)
|
Q13
|
Q13
| |
Q13
|
Q13
| |
|
Systemic therapy side effects
|
T1-T2_R
|
55
|
26% (209)
| | | | | | |
|
(Q1-Q4, Q6-Q8)
|
T1-T3_R
|
61
|
32% (190)
| | | | | | |
| |
T3-T4_R
|
77
|
39% (200)
| | | | | | |
|
Breast symptoms
|
T1-T2_R
|
114
|
51% (223)
|
Q20-Q23
|
Q20-Q23
| | | |
Q20-Q23
|
|
(Q20-Q23)
|
T1-T3_R
|
135
|
61% (223)
|
Q20-Q23
|
Q20-Q23
|
Q20-Q23
| |
Q20-Q23
|
Q20-Q23
|
| |
T3-T4_R
|
190
|
74% (258)
|
Q20-Q23
|
Q20-Q23
|
Q20-Q23
| | |
Q20-Q23
|
|
Arm symptoms
|
T1-T2_R
|
97
|
38% (255)
|
Q17-Q19
|
Q17-Q19
| | | |
Q17-Q19
|
|
(Q17-Q19)
|
T1-T3_R
|
111
|
46% (244)
|
Q17-Q19
|
Q17-Q19
| | |
Q17
|
Q17-Q19
|
| |
T3-T4_R
|
156
|
60% (260)
|
Q17
|
Q17-Q19
| | | |
Q17-Q19
|
|
Hair loss
|
T1-T2_R
|
6
|
18% (34)
|
Q5
| |
Q5
| |
Q5
| |
|
(Q5)
|
T1-T3_R
|
14
|
45% (31)
|
Q5
| |
Q5
|
Q5
|
Q5
| |
| |
T3-T4_R
|
24
|
44% (54)
|
Q5
|
Q5
| |
Q5
|
Q5
| |
- Only patients with a recalibration of 5-point at least between a pre-test and a then-test measure are incorporated in these analyses. Items with observed recalibration are listed.
- aT1 → T2_R: comparison of baseline HRQoL assessment and retrospective measure performed after surgery.
- bT1 → T3_R: comparison of baseline HRQoL assessment and retrospective measure performed three months later.
- cT3 → T4_R: comparison of HRQoL assessment at three months and retrospective measure performed three months later.
